IBDEI0JS ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8714,0)
 ;;=96360^^68^588^2^^^^1
 ;;^UTILITY(U,$J,358.3,8714,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8714,1,2,0)
 ;;=2^96360
 ;;^UTILITY(U,$J,358.3,8714,1,3,0)
 ;;=3^IV INF,HYDRATION,31-60 MIN
 ;;^UTILITY(U,$J,358.3,8715,0)
 ;;=96361^^68^588^3^^^^1
 ;;^UTILITY(U,$J,358.3,8715,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8715,1,2,0)
 ;;=2^96361
 ;;^UTILITY(U,$J,358.3,8715,1,3,0)
 ;;=3^IV INF,HYDRATION,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,8716,0)
 ;;=96365^^68^588^5^^^^1
 ;;^UTILITY(U,$J,358.3,8716,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8716,1,2,0)
 ;;=2^96365
 ;;^UTILITY(U,$J,358.3,8716,1,3,0)
 ;;=3^IV INF,THER/PROPH,UP TO 1 HR
 ;;^UTILITY(U,$J,358.3,8717,0)
 ;;=96366^^68^588^4^^^^1
 ;;^UTILITY(U,$J,358.3,8717,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8717,1,2,0)
 ;;=2^96366
 ;;^UTILITY(U,$J,358.3,8717,1,3,0)
 ;;=3^IV INF,THER/PROPH,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,8718,0)
 ;;=96374^^68^588^7^^^^1
 ;;^UTILITY(U,$J,358.3,8718,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8718,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,8718,1,3,0)
 ;;=3^IV PUSH,SINGLE/INIT SUBS/DRUG
 ;;^UTILITY(U,$J,358.3,8719,0)
 ;;=96375^^68^588^6^^^^1
 ;;^UTILITY(U,$J,358.3,8719,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8719,1,2,0)
 ;;=2^96375
 ;;^UTILITY(U,$J,358.3,8719,1,3,0)
 ;;=3^IV PUSH,EA SUBSQUENT PUSH
 ;;^UTILITY(U,$J,358.3,8720,0)
 ;;=36430^^68^588^1^^^^1
 ;;^UTILITY(U,$J,358.3,8720,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8720,1,2,0)
 ;;=2^36430
 ;;^UTILITY(U,$J,358.3,8720,1,3,0)
 ;;=3^BLOOD TRANSFUSION
 ;;^UTILITY(U,$J,358.3,8721,0)
 ;;=P9016^^68^588^11^^^^1
 ;;^UTILITY(U,$J,358.3,8721,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8721,1,2,0)
 ;;=2^P9016
 ;;^UTILITY(U,$J,358.3,8721,1,3,0)
 ;;=3^RBC,LEUKOCYTES,REDUCED
 ;;^UTILITY(U,$J,358.3,8722,0)
 ;;=S9445^^68^589^3^^^^1
 ;;^UTILITY(U,$J,358.3,8722,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8722,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,8722,1,3,0)
 ;;=3^PT EDUCATION INDIVID NON-MD
 ;;^UTILITY(U,$J,358.3,8723,0)
 ;;=G0420^^68^589^2^^^^1
 ;;^UTILITY(U,$J,358.3,8723,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8723,1,2,0)
 ;;=2^G0420
 ;;^UTILITY(U,$J,358.3,8723,1,3,0)
 ;;=3^ED SVC CKD INDIV,PER SESSION,PER HR
 ;;^UTILITY(U,$J,358.3,8724,0)
 ;;=90993^^68^589^1^^^^1
 ;;^UTILITY(U,$J,358.3,8724,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8724,1,2,0)
 ;;=2^90993
 ;;^UTILITY(U,$J,358.3,8724,1,3,0)
 ;;=3^DIALYSIS TRAINING INCOMPLETE
 ;;^UTILITY(U,$J,358.3,8725,0)
 ;;=0505F^^68^590^1^^^^1
 ;;^UTILITY(U,$J,358.3,8725,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8725,1,2,0)
 ;;=2^0505F
 ;;^UTILITY(U,$J,358.3,8725,1,3,0)
 ;;=3^HEMODIALYSIS PLAN DOCD
 ;;^UTILITY(U,$J,358.3,8726,0)
 ;;=B4164^^68^591^6^^^^1
 ;;^UTILITY(U,$J,358.3,8726,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8726,1,2,0)
 ;;=2^B4164
 ;;^UTILITY(U,$J,358.3,8726,1,3,0)
 ;;=3^ENTERAL FORMULA, CAT IV
 ;;^UTILITY(U,$J,358.3,8727,0)
 ;;=A4730^^68^591^7^^^^1
 ;;^UTILITY(U,$J,358.3,8727,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8727,1,2,0)
 ;;=2^A4730
 ;;^UTILITY(U,$J,358.3,8727,1,3,0)
 ;;=3^FISTULA CANNULATION SET, EA
 ;;^UTILITY(U,$J,358.3,8728,0)
 ;;=B5000^^68^591^9^^^^1
 ;;^UTILITY(U,$J,358.3,8728,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8728,1,2,0)
 ;;=2^B5000
 ;;^UTILITY(U,$J,358.3,8728,1,3,0)
 ;;=3^PARENT NUT SOL,ANY STRTH,RENAL
 ;;^UTILITY(U,$J,358.3,8729,0)
 ;;=A4714^^68^591^11^^^^1
